Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04432870 · ClinicalTrials.gov registry record

Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study

A clinical trial, sponsored by Massachusetts General Hospital.

Completed
Registry status
203
Enrollment target

NCT04432870: Completed study, sponsored by Massachusetts General Hospital.

NCT04432870 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 203 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04432870 has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
203 participants
Enrollment target

Study Summary

The study is a cross-sectional survey study targeting patients aged 45-75 who had their screening or surveillance colonoscopy postponed or delayed due to the COVID pandemic. Study staff will survey a random subsample of patients to assess anxiety, COVID risk tolerance, cancer worry, willingness to screen and barriers to screening colonoscopy, and preference for colonoscopy and alternative colon cancer screening options. Eligible patients will be sent a survey packet in the mail that will include a cover letter, an information sheet describing the study, an incentive, and the survey. The cover letter will include information for participants to opt-out if they desire. Patients will be asked to complete the survey and return it back to study staff. Consent is implied with return of the survey. For the study, staff plan to invite 300 patients and expect to receive 195 completed surveys. Analyses will examine whether COVID-19 has changed patients' interest in colon cancer screening and the strength of patients' preferences for colonoscopy and other approaches to colon cancer screening. It will then examine factors associated with positive and negative views on rescheduling colonoscopies such as anxiety, worry, and risk perceptions.

Trial Details

FieldValue
Enrollment Target 203 participants
Start Date 2020-06-09
Est. Completion 2021-06-30

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04432870

The ClinicalTrials.gov registry entry for NCT04432870 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04432870 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04432870 about?

NCT04432870 is a clinical study titled "Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study". The study is a cross-sectional survey study targeting patients aged 45-75 who had their screening or surveillance colonoscopy postponed or delayed due to the COVID pandemic. Study staff will survey a random subsample of patients to assess anxiety, COVID risk tolerance, cancer worry, willingness to s...

What is the current status of trial NCT04432870?

This trial is currently completed. The enrollment target is 203 participants. The study started on 2020-06-09. Estimated completion is 2021-06-30.

Who is sponsoring clinical trial NCT04432870?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.